Seeking Alpha

Alnylam Pharmaceuticals (ALNY +4.5%) gains after Rodman & Renshaw initiates the shares at...

Alnylam Pharmaceuticals (ALNY +4.5%) gains after Rodman & Renshaw initiates the shares at market outperform on valuation, saying it has a clear technological lead and strongest patent position in the RNAi space."
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector